The overall aim of the Data Analysis and Signature Generation Core is to use the experimental data from the Data Generation Core for multi-tier analyses that combine human interactome- and Gene Ontology-based statistical network models with dynamical multi-compartment ODE models to obtain multiple types of signatures. The data are characterized by the three LINCS data matrix axes;cell types are cardiomyocytes, hepatocytes, and neurons from cell lines and derived from human induced pluripotent stem cells; perturbagens are 130 individual drugs that induce cardiotoxicity, hepatotoxicity, and peripheral neuropathy and 120 drug combinations where a second drug mitigates the toxicity;assays are microarray for mRNA levels, mass spec for protein levels, and microwestern for protein state levels. The first signature tier is experimentally-observed signatures (EOS). These are lists of differentially expressed genes based on mRNA alone, protein alone, and their combination. We expect that the combination of mRNA and protein data will be synergistic for generating signatures. The second tier is network-inferred signatures (NIS). This takes EOS as input and combines it with prior knowledge (human interactome, gene expression omnibus) to generate biological networks, in the form of bipartite graphs associated with drug toxicity and its potential mitigation. Analysis of these networks will inform drug-relevant pathways for assay by microwestern array; this crosstalk between cores is a key integration point of this center proposal. The third tier is dynamical model-weighted signatures (wNIS and wEOS). The key pathways identified above by NIS will inform the development of dynamical, multi-compartment ODE models which will be constrained by the microwestern array data. Global sensitivity analysis of these dynamical models will quantify the fragility of nodes in associated networks. Thus we will weight elements of previously developed signatures by their dynamical model-predicted fragility. We expect this signature pipeline to produce roughly 4,000 signatures per year. Finally, we will use these signatures as input to build classifiers of drug-induced toxicity, using """"""""matched"""""""" (cardiomyocyte data for a cardiotoxic drug) vs. """"""""unmatched"""""""" conditions as training controls. The entire signature generating pipeline and its output will be annotated with a deep level of integrated quality control to ensure proper dissemination of our models and signatures to the public.

National Institute of Health (NIH)
National Human Genome Research Institute (NHGRI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-CB-D (50))
Program Officer
Ajay, Ajay
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Icahn School of Medicine at Mount Sinai
New York
United States
Zip Code
Jones, DeAnalisa C; Gong, Jingqi Q X; Sobie, Eric A (2018) A privileged role for neuronal Na+ channels in regulating ventricular [Ca2+] and arrhythmias. J Gen Physiol 150:901-905
Barrette, Anne Marie; Bouhaddou, Mehdi; Birtwistle, Marc R (2018) Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials. ACS Chem Neurosci 9:118-129
Keenan, Alexandra B; Jenkins, Sherry L; Jagodnik, Kathleen M et al. (2018) The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. Cell Syst 6:13-24
Bouhaddou, Mehdi; Barrette, Anne Marie; Stern, Alan D et al. (2018) A mechanistic pan-cancer pathway model informed by multi-omics data interprets stochastic cell fate responses to drugs and mitogens. PLoS Comput Biol 14:e1005985
Koch, Rick J; Barrette, Anne Marie; Stern, Alan D et al. (2018) Validating Antibodies for Quantitative Western Blot Measurements with Microwestern Array. Sci Rep 8:11329
Xiong, Yuguang; Soumillon, Magali; Wu, Jie et al. (2017) A Comparison of mRNA Sequencing with Random Primed and 3'-Directed Libraries. Sci Rep 7:14626
Shim, Jaehee V; Chun, Bryan; van Hasselt, Johan G C et al. (2017) Mechanistic Systems Modeling to Improve Understanding and Prediction of Cardiotoxicity Caused by Targeted Cancer Therapeutics. Front Physiol 8:651
Gong, Jingqi Q X; Shim, Jaehee V; Núñez-Acosta, Elisa et al. (2017) I love it when a plan comes together: Insight gained through convergence of competing mathematical models. J Mol Cell Cardiol 102:31-33
Stern, Alan D; Rahman, Adeeb H; Birtwistle, Marc R (2017) Cell size assays for mass cytometry. Cytometry A 91:14-24
Stillitano, Francesca; Hansen, Jens; Kong, Chi-Wing et al. (2017) Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells. Elife 6:

Showing the most recent 10 out of 16 publications